Journal Home > Volume 10 , Issue 2
Journal of Neurorestoratology 2022, 10(2): 100005 https://doi.org/10.1016/j.jnrt.2022.100005
Practice Guidelines | Open Access | Issue | Published: 14 June 2022

Guideline of clinical neurorestorative treatment for brain trauma (2022 China version)

Show Author's Information Xiaofeng Yanga( ),  Lin Chenb,  Jiangbo Puc,  Yusheng Lid,  Jinquan Caie,  Lukui Chenf,  Shiqing Fengg,  Jianghong Heh,  Yunliang Wangi,  Sai Zhangj,  Shixiang Chengjk,  Hongyun Huangl( )
The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang, China
Department of Neurosurgery, Dongzhimen Hospital, Beijing University of Traditional Chinese Medicine, Beijing 100700, China
Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China
First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China
Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, Helongjiang, China
Department of Neurosurgery, Neuroscience Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510310, Guangdong, China
Department of Orthopedics, Tianjin Medical University General Hospital, Tianjin 300052, China
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China
Department of Neurology, The 960 Hospital of Joint Support Force of PLA, Zibo 255300, Shandong, China
Xincheng Hospital of Tianjin University, Tianjin 300467, China
Healthina Academy of Cellular Intelligence Manufacturing & Neurotrauma Repair of Tianjin Economic-Technological Development Area (ACMN-TEDA), Tianjin 300467, China
Beijing Hongtianji Neuroscience Academy, Beijing 100143, China
Keywords:
Guideline, Traumatic brain injury, Neurorestorative treatments
Cite this article:
Yang X, Chen L, Pu J, et al. Guideline of clinical neurorestorative treatment for brain trauma (2022 China version). Journal of Neurorestoratology, 2022, 10(2): 100005. https://doi.org/10.1016/j.jnrt.2022.100005
Download citation
EndNote(RIS)
BibTeX

2004

Views

619

Downloads

Citations

6

Crossref

6

WoS

0

Scopus

N/A

CSCD

Abstract Full text Electronic supplementary material About this article

Brain trauma or traumatic brain injury (TBI) is one of the leading causes of death and disability worldwide. Along with the conventional therapeutic strategies, neurorestorative treatments for TBI have been developed in recent decades. However, missing standards and guidelines has become a growing issue both in clinical practice and fundamental research. Consequently, the Chinese Association of Neurorestoratology (Preparatory; CANR) and the China Committee of International Association of Neurorestoratology (IANR-China Committee) have reached a consensus to form and approve the Guideline of Clinical Neurorestorative Treatment for Brain Trauma. This guideline addresses the common issues in the evaluation and therapies of TBI patients within the scope of Neurorestoratology, offers recommendations based on state-of-art clinical evidences, and covers cell therapies, neural stimulation therapies, and pharmaceutical therapies. Hopefully, this guideline may provide references to clinical professionals during diagnosis and treatment, maximizing the neurorestorative therapeutic efficacy.


menu
Abstract
Full text
Outline
Electronic supplementary material
About this article

Guideline of clinical neurorestorative treatment for brain trauma (2022 China version)

Show Author's information Xiaofeng Yanga( ), Lin Chenb, Jiangbo Puc, Yusheng Lid, Jinquan Caie, Lukui Chenf, Shiqing Fengg, Jianghong Heh, Yunliang Wangi, Sai Zhangj, Shixiang Chengjk, Hongyun Huangl( )
The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang, China
Department of Neurosurgery, Dongzhimen Hospital, Beijing University of Traditional Chinese Medicine, Beijing 100700, China
Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China
First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China
Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, Helongjiang, China
Department of Neurosurgery, Neuroscience Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510310, Guangdong, China
Department of Orthopedics, Tianjin Medical University General Hospital, Tianjin 300052, China
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China
Department of Neurology, The 960 Hospital of Joint Support Force of PLA, Zibo 255300, Shandong, China
Xincheng Hospital of Tianjin University, Tianjin 300467, China
Healthina Academy of Cellular Intelligence Manufacturing & Neurotrauma Repair of Tianjin Economic-Technological Development Area (ACMN-TEDA), Tianjin 300467, China
Beijing Hongtianji Neuroscience Academy, Beijing 100143, China

Abstract

Brain trauma or traumatic brain injury (TBI) is one of the leading causes of death and disability worldwide. Along with the conventional therapeutic strategies, neurorestorative treatments for TBI have been developed in recent decades. However, missing standards and guidelines has become a growing issue both in clinical practice and fundamental research. Consequently, the Chinese Association of Neurorestoratology (Preparatory; CANR) and the China Committee of International Association of Neurorestoratology (IANR-China Committee) have reached a consensus to form and approve the Guideline of Clinical Neurorestorative Treatment for Brain Trauma. This guideline addresses the common issues in the evaluation and therapies of TBI patients within the scope of Neurorestoratology, offers recommendations based on state-of-art clinical evidences, and covers cell therapies, neural stimulation therapies, and pharmaceutical therapies. Hopefully, this guideline may provide references to clinical professionals during diagnosis and treatment, maximizing the neurorestorative therapeutic efficacy.

Keywords: Guideline, Traumatic brain injury, Neurorestorative treatments

References(83)

1.
JiangJYGaoGYFengJFTraumatic brain injury in ChinaLancet Neurol2019183286295

Jiang JY, Gao GY, Feng JF, et al. Traumatic brain injury in China. Lancet Neurol. 2019, 18(3): 286-295.

10.1016/S1474-4422(18)30469-1
DOI Google Scholar
2.
TBI-related Emergency Department Visits, Hospitalizations, and deaths (EDHDs). Centers for disease control and prevention. 2019. https://www.cdc.gov/traumaticbraininjury/data/tbi-edhd.html. Accessed 2021/03/18 2021.
3.
ChengPXYinPNingPSTrends in traumatic brain injury mortality in China, 2006-2013: a population-based longitudinal studyPLoS Med2017147e100233210.1371/journal.pmed.1002332

Cheng PX, Yin P, Ning PS, et al. Trends in traumatic brain injury mortality in China, 2006-2013: a population-based longitudinal study. PLoS Med. 2017, 14(7): e1002332.
DOI Google Scholar
4.
MajdanMPlancikovaDBrazinovaAEpidemiology of traumatic brain injuries in Europe: a cross-sectional analysisLancet Public Health201612e76e83

Majdan M, Plancikova D, Brazinova A, et al. Epidemiology of traumatic brain injuries in Europe: a cross-sectional analysis. Lancet Public Health. 2016, 1(2): e76-e83.

10.1016/S2468-2667(16)30017-2
DOI Google Scholar
5.
HuiJYGongRLiangYMChinese head trauma data bank: factors of short-term prognosis (in Chinese)Chin J Neurosurg20143015658

Hui JY, Gong R, Liang YM, et al. Chinese head trauma data bank: factors of short-term prognosis (in Chinese). Chin J Neurosurg. 2014, 30(1): 56-58.
Google Scholar
6.
RosenfeldJVMaasAIBraggePEarly management of severe traumatic brain injuryLancet2012380984710881098

Rosenfeld JV, Maas AI, Bragge P, et al. Early management of severe traumatic brain injury. Lancet. 2012, 380(9847): 1088-1098.

10.1016/S0140-6736(12)60864-2
DOI Google Scholar
7.
SteinSCGeorgoffPMeghanS150 years of treating severe traumatic brain injury: a systematic review of progress in mortalityJ Neurotrauma20102771343135310.1089/neu.2009.1206

Stein SC, Georgoff P, Meghan S, et al. 150 years of treating severe traumatic brain injury: a systematic review of progress in mortality. J Neurotrauma. 2010, 27(7): 1343-1353.
DOI Google Scholar
8.
HutchinsonPJKoliasAGTimofeevISTrial of decompressive craniectomy for traumatic intracranial hypertensionN Engl J Med2016375121119113010.1056/NEJMoa1605215

Hutchinson PJ, Kolias AG, Timofeev IS, et al. Trial of decompressive craniectomy for traumatic intracranial hypertension. N Engl J Med. 2016, 375(12): 1119-1130.
DOI Google Scholar
9.
HuiJYFengJFTuYSafety and efficacy of long-term mild hypothermia for severe traumatic brain injury with refractory intracranial hypertension (LTH-1): a multicenter randomized controlled trialEClinicalMedicine202132100732

Hui JY, Feng JF, Tu Y, et al. Safety and efficacy of long-term mild hypothermia for severe traumatic brain injury with refractory intracranial hypertension (LTH-1): a multicenter randomized controlled trial. EClinicalMedicine. 2021, 32: 100732.

10.1016/j.eclinm.2021.100732
DOI Google Scholar
10.
BoutinAMooreLLauzierFTransfusion of red blood cells in patients with traumatic brain injuries admitted to Canadian trauma health centres: a multicentre cohort studyBMJ Open201773e01447210.1136/bmjopen-2016-014472

Boutin A, Moore L, Lauzier F, et al. Transfusion of red blood cells in patients with traumatic brain injuries admitted to Canadian trauma health centres: a multicentre cohort study. BMJ Open. 2017, 7(3): e014472.
DOI Google Scholar
11.
ZhangZXGuanLXZhangKA combined procedure to deliver autologous mesenchymal stromal cells to patients with traumatic brain injuryCytotherapy200810213413910.1080/14653240701883061

Zhang ZX, Guan LX, Zhang K, et al. A combined procedure to deliver autologous mesenchymal stromal cells to patients with traumatic brain injury. Cytotherapy. 2008, 10(2): 134-139.
DOI Google Scholar
12.

Xiong Y, Mahmood A, Chopp M. Neurorestorative treatments for traumatic brain injury. Discov Med. 2010, 10(54): 434-442.
Google Scholar
13.
HellewellSCConquestALittleLEPO treatment does not alter acute serum profiles of GFAP and S100B after TBI: a brief report on the Australian EPO-TBI clinical trialJ Clin Neurosci20207658

Hellewell SC, Conquest A, Little L, et al. EPO treatment does not alter acute serum profiles of GFAP and S100B after TBI: a brief report on the Australian EPO-TBI clinical trial. J Clin Neurosci. 2020, 76: 5-8.

10.1016/j.jocn.2020.04.081
DOI Google Scholar
14.
RobertsonCSHannayHJYamalJMEffect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trialJAMA20143121364710.1001/jama.2014.6490

Robertson CS, Hannay HJ, Yamal JM, et al. Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial. JAMA. 2014, 312(1): 36-47.
DOI Google Scholar
15.
SchiffNDGiacinoJTKalmarKBehavioural improvements with thalamic stimulation after severe traumatic brain injuryNature2007448715360060310.1038/nature06041

Schiff ND, Giacino JT, Kalmar K, et al. Behavioural improvements with thalamic stimulation after severe traumatic brain injury. Nature. 2007, 448(7153): 600-603.
DOI Google Scholar
16.
DemertziATagliazucchiEDehaeneSHuman consciousness is supported by dynamic complex patterns of brain signal coordinationSci Adv201952eaat7603

Demertzi A, Tagliazucchi E, Dehaene S, et al. Human consciousness is supported by dynamic complex patterns of brain signal coordination. Sci Adv. 2019, 5(2): eaat7603.

10.1126/sciadv.aat7603
DOI Google Scholar
17.

Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet. 1975, 1(7905): 480-484.
DOI Google Scholar
18.
TeasdaleGMPettigrewLEWilsonJTAnalyzing outcome of treatment of severe head injury: a review and update on advancing the use of the Glasgow Outcome ScaleJ Neurotrauma199815858759710.1089/neu.1998.15.587

Teasdale GM, Pettigrew LE, Wilson JT, et al. Analyzing outcome of treatment of severe head injury: a review and update on advancing the use of the Glasgow Outcome Scale. J Neurotrauma. 1998, 15(8): 587-597.
DOI Google Scholar
19.
WilsonJTPettigrewLETeasdaleGMStructured interviews for the Glasgow outcome scale and the extended Glasgow outcome scale: guidelines for their useJ Neurotrauma199815857358510.1089/neu.1998.15.573

Wilson JT, Pettigrew LE, Teasdale GM. Structured interviews for the Glasgow outcome scale and the extended Glasgow outcome scale: guidelines for their use. J Neurotrauma. 1998, 15(8): 573-585.
DOI Google Scholar
20.

American Congress of Rehabilitation Medicine, Brain Injury-Interdisciplinary Special Interest Group, Seel RT, Sherer M, et al, Brain Injury Interdisciplinary Special Interest Group American Congress of Rehabilitation Medicine. Assessment scales for disorders of consciousness: evidence-based recommendations for clinical practice and research. Arch Phys Med Rehabil. 2010, 91(12): 1795-1813.
Google Scholar
21.
GiacinoJTKatzDISchiffNDPractice guideline update recommendations summary: disorders of consciousness: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology; the American congress of rehabilitation medicine; and the national institute on disability, independent living, and rehabilitation researchNeurology2018911045046010.1212/wnl.0000000000005926

Giacino JT, Katz DI, Schiff ND, et al. Practice guideline update recommendations summary: disorders of consciousness: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology; the American congress of rehabilitation medicine; and the national institute on disability, independent living, and rehabilitation research. Neurology. 2018, 91(10): 450-460.
DOI Google Scholar
22.
KotchoubeyBYuTMuellerFTrue or false? Activations of language-related areas in patients with disorders of consciousnessCurr Pharmaceut Des2014202642394247

Kotchoubey B, Yu T, Mueller F, et al. True or false? Activations of language-related areas in patients with disorders of consciousness. Curr Pharmaceut Des. 2014, 20(26): 4239-4247.
Google Scholar
23.
MontiMMRosenbergMFinoiaPThalamo-frontal connectivity mediates top-down cognitive functions in disorders of consciousnessNeurology2015842167173

Monti MM, Rosenberg M, Finoia P, et al. Thalamo-frontal connectivity mediates top-down cognitive functions in disorders of consciousness. Neurology. 2015, 84(2): 167-173.

10.1212/WNL.0000000000001123
DOI Google Scholar
24.

Snider SB, Edlow BL. MRI in disorders of consciousness. Curr Opin Neurol. 2020, 33(6): 676-683.
DOI Google Scholar
25.
SittJDKingJREl KarouiILarge scale screening of neural signatures of consciousness in patients in a vegetative or minimally conscious stateBrain2014137Pt 82258227010.1093/brain/awu141

Sitt JD, King JR, El Karoui I, et al. Large scale screening of neural signatures of consciousness in patients in a vegetative or minimally conscious state. Brain. 2014, 137(Pt 8): 2258-2270.
DOI Google Scholar
26.
KondziellaDBenderADiserensKEuropean Academy of Neurology guideline on the diagnosis of Coma and other disorders of consciousnessEur J Neurol202027574175610.1111/ene.14151

Kondziella D, Bender A, Diserens K, et al. European Academy of Neurology guideline on the diagnosis of Coma and other disorders of consciousness. Eur J Neurol. 2020, 27(5): 741-756.
DOI Google Scholar
27.
StenderJGosseriesOBrunoMADiagnostic precision of PET imaging and functional MRI in disorders of consciousness: a clinical validation studyLancet20143849942514522

Stender J, Gosseries O, Bruno MA, et al. Diagnostic precision of PET imaging and functional MRI in disorders of consciousness: a clinical validation study. Lancet. 2014, 384(9942): 514-522.

10.1016/S0140-6736(14)60042-8
DOI Google Scholar
28.
LutkenhoffESNigriARossi SebastianoDEEG Power spectra and subcortical pathology in chronic disorders of consciousnessPsychol Med202011010.1017/S003329172000330X

Lutkenhoff ES, Nigri A, Rossi Sebastiano D, et al. EEG Power spectra and subcortical pathology in chronic disorders of consciousness. Psychol Med. 2020: 1-10, doi 10.1017/S003329172000330X.
DOI Google Scholar
29.
BarehamCARobertsNAllansonJBedside EEG predicts longitudinal behavioural changes in disorders of consciousnessNeuroimage Clin202028102372

Bareham CA, Roberts N, Allanson J, et al. Bedside EEG predicts longitudinal behavioural changes in disorders of consciousness. Neuroimage Clin. 2020, 28: 102372.

10.1016/j.nicl.2020.102372
DOI Google Scholar
30.
LesenfantsDHabbalDChatelleCElectromyographic decoding of response to command in disorders of consciousnessNeurology2016872020992107

Lesenfants D, Habbal D, Chatelle C, et al. Electromyographic decoding of response to command in disorders of consciousness. Neurology. 2016, 87(20): 2099-2107.

10.1212/WNL.0000000000003333
DOI Google Scholar
31.
PandyanADJohnsonGRPriceCIA review of the properties and limitations of the Ashworth and modified Ashworth Scales as measures of spasticityClin Rehabil1999135373383

Pandyan AD, Johnson GR, Price CI, et al. A review of the properties and limitations of the Ashworth and modified Ashworth Scales as measures of spasticity. Clin Rehabil. 1999, 13(5): 373-383.

10.1191/026921599677595404
DOI Google Scholar
32.
CarrJHShepherdRBNordholmLInvestigation of a new motor assessment scale for stroke patientsPhys Ther198565217518010.1093/ptj/65.2.175

Carr JH, Shepherd RB, Nordholm L, et al. Investigation of a new motor assessment scale for stroke patients. Phys Ther. 1985, 65(2): 175-180.
DOI Google Scholar
33.

Kristensen OH, Stenager E, Dalgas U. Muscle strength and poststroke hemiplegia: a systematic review of muscle strength assessment and muscle strength impairment. Arch Phys Med Rehabil. 2017, 98(2): 368-380.
DOI Google Scholar
34.
FauziAAPrihastomoKTRanuhIGMARClinical outcomes of MLC601 (NeuroAiD TM) in traumatic brain injury: a pilot studyBrain Sci20201026010.25124/ijies.v4i02.75

Fauzi AA, Prihastomo KT, Ranuh IGMAR, et al. Clinical outcomes of MLC601 (NeuroAiD TM) in traumatic brain injury: a pilot study. Brain Sci. 2020, 10(2): 60.
DOI Google Scholar
35.

Meseguer-Henarejos AB, Sánchez-Meca J, López-Pina JA, et al. Inter- and intra-rater reliability of the Modified Ashworth Scale: a systematic review and meta-analysis. Eur J Phys Rehabil Med. 2018, 54(4): 576-590.
DOI Google Scholar
36.
RichardsonRMSinghASunDStem cell biology in traumatic brain injury: effects of injury and strategies for repairJ Neurosurg2010112511251138

Richardson RM, Singh A, Sun D, et al. Stem cell biology in traumatic brain injury: effects of injury and strategies for repair. J Neurosurg. 2010, 112(5): 1125-1138.

10.3171/2009.4.JNS081087
DOI Google Scholar
37.
GennaiSMonselAHaoQCell-based therapy for traumatic brain injuryBr J Anaesth2015115220321210.1093/bja/aev229

Gennai S, Monsel A, Hao Q, et al. Cell-based therapy for traumatic brain injury. Br J Anaesth. 2015, 115(2): 203-212.
DOI Google Scholar
38.
SeledtsovVIRabinovichSSParlyukOVCell transplantation therapy in re-animating severely head-injured patientsBiomed Pharmacother2005597415420

Seledtsov VI, Rabinovich SS, Parlyuk OV, et al. Cell transplantation therapy in re-animating severely head-injured patients. Biomed Pharmacother. 2005, 59(7): 415-420.

10.1016/j.biopha.2005.01.012
DOI Google Scholar
39.
SeledtsovVIRabinovichSSKashchenkoEAImmunological and clinical aspects of cell therapy in the treatment of aftereffects of craniocerebral injuryBull Exp Biol Med2006141112112310.1007/s10517-006-0110-7

Seledtsov VI, Rabinovich SS, Kashchenko EA, et al. Immunological and clinical aspects of cell therapy in the treatment of aftereffects of craniocerebral injury. Bull Exp Biol Med. 2006, 141(1): 121-123.
DOI Google Scholar
40.
SeledtsovVIRabinovichSSParlyukOVCell therapy of comatose statesBull Exp Biol Med2006142112913210.1007/s10517-006-0310-1

Seledtsov VI, Rabinovich SS, Parlyuk OV, et al. Cell therapy of comatose states. Bull Exp Biol Med. 2006, 142(1): 129-132.
DOI Google Scholar
41.
HuangHYChenLXiHTOlfactory ensheathing cells transplantation for central nervous system diseases in 1,255 patients (in Chinese)Chin J Reparative Reconstr Surg20092311420

Huang HY, Chen L, Xi HT, et al. Olfactory ensheathing cells transplantation for central nervous system diseases in 1,255 patients (in Chinese). Chin J Reparative Reconstr Surg. 2009, 23(1): 14-20.
Google Scholar
42.
Cox CSJrBaumgartnerJEHartingMTAutologous bone marrow mononuclear cell therapy for severe traumatic brain injury in childrenNeurosurgery2011683588600

Cox CS Jr, Baumgartner JE, Harting MT, et al. Autologous bone marrow mononuclear cell therapy for severe traumatic brain injury in children. Neurosurgery. 2011, 68(3): 588-600.

10.1227/NEU.0b013e318207734c
DOI Google Scholar
43.
LiaoGPHartingMTHetzRAAutologous bone marrow mononuclear cells reduce therapeutic intensity for severe traumatic brain injury in childrenPediatr Crit Care Med2015163245255

Liao GP, Harting MT, Hetz RA, et al. Autologous bone marrow mononuclear cells reduce therapeutic intensity for severe traumatic brain injury in children. Pediatr Crit Care Med. 2015;16(3):245-255.

10.1097/PCC.0000000000000324
DOI Google Scholar
44.
Cox CSJrHetzRALiaoGPTreatment of severe adult traumatic brain injury using bone marrow mononuclear cellsStem Cell20173541065107910.1002/stem.2538

Cox CS Jr, Hetz RA, Liao GP, et al. Treatment of severe adult traumatic brain injury using bone marrow mononuclear cells. Stem Cell. 2017, 35(4): 1065-1079.
DOI Google Scholar
45.
SharmaASaneHKulkarniPCell therapy attempted as a novel approach for chronic traumatic brain injury - a pilot studySpringerPlus201542610.3923/jest.2016.26.48

Sharma A, Sane H, Kulkarni P, et al. Cell therapy attempted as a novel approach for chronic traumatic brain injury - a pilot study. SpringerPlus. 2015, 4: 26.
DOI Google Scholar
46.
SharmaAKSaneHMKulkarniPPAutologous bone marrow mononuclear cell transplantation in patients with chronic traumatic brain injury- a clinical studyCell Regen2020913

Sharma AK, Sane HM, Kulkarni PP, et al. Autologous bone marrow mononuclear cell transplantation in patients with chronic traumatic brain injury- a clinical study. Cell Regen. 2020, 9(1): 3.

10.1186/s13619-020-00043-7
DOI Google Scholar
47.
WangSChengHBDaiGHUmbilical cord mesenchymal stem cell transplantation significantly improves neurological function in patients with sequelae of traumatic brain injuryBrain Res201315327684

Wang S, Cheng HB, Dai GH, et al. Umbilical cord mesenchymal stem cell transplantation significantly improves neurological function in patients with sequelae of traumatic brain injury. Brain Res. 2013, 1532: 76-84.

10.1016/j.brainres.2013.08.001
DOI Google Scholar
48.
DominiciMle BlancKMuellerIMinimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy20068431531710.1080/14653240600855905

Dominici M, le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006, 8(4): 315-317.
DOI Google Scholar
49.
TianCLWangXWWangXDAutologous bone marrow mesenchymal stem cell therapy in the subacute stage of traumatic brain injury by lumbar punctureExp Clin Transplant201311217618110.6002/ect.2012.0053

Tian CL, Wang XW, Wang XD, et al. Autologous bone marrow mesenchymal stem cell therapy in the subacute stage of traumatic brain injury by lumbar puncture. Exp Clin Transplant. 2013, 11(2): 176-181.
DOI Google Scholar
50.
LuanZQuSQDuKNeural stem/progenitor cell transplantation for cortical visual impairment in neonatal brain injured patientsCell Transplant201322Suppl 1S101S112

Luan Z, Qu SQ, Du K, et al. Neural stem/progenitor cell transplantation for cortical visual impairment in neonatal brain injured patients. Cell Transplant. 2013, 22(Suppl 1): S101-S112.

10.3727/096368913X672163
DOI Google Scholar
51.
WangZGLuoYChenLASafety of neural stem cell transplantation in patients with severe traumatic brain injuryExp Ther Med201713636133618

Wang ZG, Luo Y, Chen LA, et al. Safety of neural stem cell transplantation in patients with severe traumatic brain injury. Exp Ther Med. 2017, 13(6): 3613-3618.

10.3892/etm.2017.4423
DOI Google Scholar
52.
KawaboriMWeintraubAHImaiHCell therapy for chronic TBI: interim analysis of the randomized controlled STEMTRA trialNeurology2021968e1202e121410.1212/wnl.0000000000011450

Kawabori M, Weintraub AH, Imai H, et al. Cell therapy for chronic TBI: interim analysis of the randomized controlled STEMTRA trial. Neurology. 2021, 96(8): e1202-e1214.
DOI Google Scholar
53.
CozeneBSadanandanNFarooqJMesenchymal stem cell-induced anti-neuroinflammation against traumatic brain injuryCell Transplant2021309636897211035715

Cozene B, Sadanandan N, Farooq J, et al. Mesenchymal stem cell-induced anti-neuroinflammation against traumatic brain injury. Cell Transplant. 2021, 30: 9636897211035715.

10.1177/09636897211035715
DOI Google Scholar
54.
LiYSHeJHYangBClinical diagnosis guidelines and neurorestorative treatment for chronic disorders of consciousness (2021 China version)J Neurorestoratol202191505910.26599/jnr.2021.9040006

Li YS, He JH, Yang B, et al. Clinical diagnosis guidelines and neurorestorative treatment for chronic disorders of consciousness (2021 China version). J Neurorestoratol. 2021, 9(1): 50-59.
DOI Google Scholar
55.

Raguž M, Predrijevac N, Dlaka D, et al. Structural changes in brains of patients with disorders of consciousness treated with deep brain stimulation. Sci Rep. 2021, 11(1): 4401.
DOI Google Scholar
56.
Louise-Bender PapeTRosenowJLewisGRepetitive transcranial magnetic stimulation-associated neurobehavioral gains during coma recoveryBrain Stimul2009212235

Louise-Bender Pape T, Rosenow J, Lewis G, et al. Repetitive transcranial magnetic stimulation-associated neurobehavioral gains during coma recovery. Brain Stimul. 2009, 2(1): 22-35.

10.1016/j.brs.2008.09.004
DOI Google Scholar
57.
ManganottiPFormaggioEStortiSFEffect of high-frequency repetitive transcranial magnetic stimulation on brain excitability in severely brain-injured patients in minimally conscious or vegetative stateBrain Stimul201366913921

Manganotti P, Formaggio E, Storti SF, et al. Effect of high-frequency repetitive transcranial magnetic stimulation on brain excitability in severely brain-injured patients in minimally conscious or vegetative state. Brain Stimul. 2013, 6(6): 913-921.

10.1016/j.brs.2013.06.006
DOI Google Scholar
58.
MollicaASafavifarFFralickMTranscranial magnetic stimulation for the treatment of concussion: a systematic reviewNeuromodulation202124580381210.1111/ner.13319

Mollica A, Safavifar F, Fralick M, et al. Transcranial magnetic stimulation for the treatment of concussion: a systematic review. Neuromodulation. 2021, 24(5): 803-812.
DOI Google Scholar
59.

Kang DH, Kim GW. Changes in diffuse tensor imaging and therapeutic effect of repetitive transcranial magnetic stimulation in traumatic brain injury with central pain. Brain Sci. 2020, 10(12): E929.
DOI Google Scholar
60.
LeiJWangLGaoGYRight Median nerve electrical stimulation for acute traumatic Coma patientsJ Neurotrauma201532201584158910.1089/neu.2014.3768

Lei J, Wang L, Gao GY, et al. Right Median nerve electrical stimulation for acute traumatic Coma patients. J Neurotrauma. 2015, 32(20): 1584-1589.
DOI Google Scholar
61.
ZhangXLiuBHLiNTranscranial direct current stimulation over prefrontal areas improves psychomotor inhibition state in patients with traumatic brain injury: a pilot studyFront Neurosci202014386

Zhang X, Liu BH, Li N, et al. Transcranial direct current stimulation over prefrontal areas improves psychomotor inhibition state in patients with traumatic brain injury: a pilot study. Front Neurosci. 2020, 14: 386.

10.3389/fnins.2020.00386
DOI Google Scholar
62.
RushbyJAde BlasioFMLoganJAtDCS effects on task-related activation and working memory performance in traumatic brain injury: a within group randomized controlled trialNeuropsychol Rehabil202131581483610.1080/09602011.2020.1733620

Rushby JA, de Blasio FM, Logan JA, et al. tDCS effects on task-related activation and working memory performance in traumatic brain injury: a within group randomized controlled trial. Neuropsychol Rehabil. 2021, 31(5): 814-836.
DOI Google Scholar
63.
NicholAFrenchCLittleLErythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trialLancet20153861001224992506

Nichol A, French C, Little L, et al. Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial. Lancet. 2015, 386(10012): 2499-2506.

10.1016/S0140-6736(15)00386-4
DOI Google Scholar
64.
KnottRJHarrisAHigginsACost-effectiveness of erythropoietin in traumatic brain injury: a multinational trial-based economic analysisJ Neurotrauma201936172541254810.1089/neu.2018.6229

Knott RJ, Harris A, Higgins A, et al. Cost-effectiveness of erythropoietin in traumatic brain injury: a multinational trial-based economic analysis. J Neurotrauma. 2019, 36(17): 2541-2548.
DOI Google Scholar
65.
SkrifvarsMBBaileyMFrenchCErythropoietin in patients with traumatic brain injury and extracranial injury-A post hoc analysis of the erythropoietin traumatic brain injury trialJ Trauma Acute Care Surg2017833449456

Skrifvars MB, Bailey M, French C, et al. Erythropoietin in patients with traumatic brain injury and extracranial injury-A post hoc analysis of the erythropoietin traumatic brain injury trial. J Trauma Acute Care Surg. 2017, 83(3): 449-456.

10.1097/TA.0000000000001594
DOI Google Scholar
66.
SkrifvarsMBFrenchCBaileyMCause and timing of death and subgroup differential effects of erythropoietin in the EPO-TBI studyJ Neurotrauma2018352333340

Skrifvars MB, French C, Bailey M, et al. Cause and timing of death and subgroup differential effects of erythropoietin in the EPO-TBI study. J Neurotrauma. 2018, 35(2): 333-340.

10.1089/neu.2017.5135
DOI Google Scholar
67.
LiZMXiaoYLZhuJXRecombinant human erythropoietin improves functional recovery in patients with severe traumatic brain injury: a randomized, double blind and controlled clinical trialClin Neurol Neurosurg20161508083

Li ZM, Xiao YL, Zhu JX, et al. Recombinant human erythropoietin improves functional recovery in patients with severe traumatic brain injury: a randomized, double blind and controlled clinical trial. Clin Neurol Neurosurg. 2016, 150: 80-83.

10.1016/j.clineuro.2016.09.001
DOI Google Scholar
68.
LiuCLHuangCSXieJPotential efficacy of erythropoietin on reducing the risk of mortality in patients with traumatic brain injury: a systematic review and meta-analysisBioMed Res Int

Liu CL, Huang CS, Xie J, et al. Potential efficacy of erythropoietin on reducing the risk of mortality in patients with traumatic brain injury: a systematic review and meta-analysis. BioMed Res Int. 2020, 2020: 7563868.
Google Scholar
69.
LiuMTWangAJChenYEfficacy and safety of erythropoietin for traumatic brain injuryBMC Neurol2020201399

Liu MT, Wang AJ, Chen Y, et al. Efficacy and safety of erythropoietin for traumatic brain injury. BMC Neurol. 2020, 20(1): 399.

10.1186/s12883-020-01958-z
DOI Google Scholar
70.
GantnerDCBaileyMPresneillJErythropoietin to reduce mortality in traumatic brain injury: a post-hoc dose-effect analysisAnn Surg2018267358558910.1097/sla.0000000000002142

Gantner DC, Bailey M, Presneill J, et al. Erythropoietin to reduce mortality in traumatic brain injury: a post-hoc dose-effect analysis. Ann Surg. 2018, 267(3): 585-589.
DOI Google Scholar
71.
FarzaneganGRDerakhshanNKhaliliHEffects of atorvastatin on brain contusion volume and functional outcome of patients with moderate and severe traumatic brain injury; a randomized double-blind placebo-controlled clinical trialJ Clin Neurosci201744143147

Farzanegan GR, Derakhshan N, Khalili H, et al. Effects of atorvastatin on brain contusion volume and functional outcome of patients with moderate and severe traumatic brain injury; a randomized double-blind placebo-controlled clinical trial. J Clin Neurosci. 2017, 44: 143-147.

10.1016/j.jocn.2017.06.010
DOI Google Scholar
72.
Tapia-PerezJHSanchez-AguilarMTorres-CorzoJGEffect of rosuvastatin on Amnesia and disorientation after traumatic brain injury (NCT003229758)J Neurotrauma20082581011101710.1089/neu.2008.0554

Tapia-Perez JH, Sanchez-Aguilar M, Torres-Corzo JG, et al. Effect of rosuvastatin on Amnesia and disorientation after traumatic brain injury (NCT003229758). J Neurotrauma. 2008, 25(8): 1011-1017.
DOI Google Scholar
73.

Redelmeier DA, Manzoor F, Thiruchelvam D. Association between statin use and risk of dementia after a concussion. JAMA Neurol. 2019, 76(8): 887-896.
DOI Google Scholar
74.
OrtegaFJJolkkonenJMahyNGlibenclamide enhances neurogenesis and improves long-term functional recovery after transient focal cerebral ischemiaJ Cerebr Blood Flow Metabol201333335636410.1038/jcbfm.2012.166

Ortega FJ, Jolkkonen J, Mahy N, et al. Glibenclamide enhances neurogenesis and improves long-term functional recovery after transient focal cerebral ischemia. J Cerebr Blood Flow Metabol. 2013, 33(3): 356-364.
DOI Google Scholar
75.
KhaliliHDerakhshanNNiakanAEffects of oral glibenclamide on brain contusion volume and functional outcome of patients with moderate and severe traumatic brain injuries: a randomized double-blind placebo-controlled clinical trialWorld Neurosurg2017101130136

Khalili H, Derakhshan N, Niakan A, et al. Effects of oral glibenclamide on brain contusion volume and functional outcome of patients with moderate and severe traumatic brain injuries: a randomized double-blind placebo-controlled clinical trial. World Neurosurg. 2017, 101: 130-136.

10.1016/j.wneu.2017.01.103
DOI Google Scholar
76.
SmithJMLungaPStoryDInosine promotes recovery of skilled motor function in a model of focal brain injuryBrain2007130Pt 4915925

Smith JM, Lunga P, Story D, et al. Inosine promotes recovery of skilled motor function in a model of focal brain injury. Brain. 2007, 130(Pt 4): 915-925.

10.1093/brain/awl393
DOI Google Scholar
77.
DachirSShabashovDTrembovlerVInosine improves functional recovery after experimental traumatic brain injuryBrain Res201415557888

Dachir S, Shabashov D, Trembovler V, et al. Inosine improves functional recovery after experimental traumatic brain injury. Brain Res. 2014, 1555: 78-88.

10.1016/j.brainres.2014.01.044
DOI Google Scholar
78.
WangLYZhangDRenYKInjectable hyaluronic acid hydrogel loaded with BMSC and NGF for traumatic brain injury treatmentMater Today Bio202113100201

Wang LY, Zhang D, Ren YK, et al. Injectable hyaluronic acid hydrogel loaded with BMSC and NGF for traumatic brain injury treatment. Mater Today Bio. 2021, 13: 100201.

10.1016/j.mtbio.2021.100201
DOI Google Scholar
79.

Wang Y, Jia F, Lin Y. Poly(butyl cyanoacrylate) nanoparticles-delivered β-nerve growth factor promotes the neurite outgrowth and reduces the mortality in the rat after traumatic brain injury. Nanotechnology. 2022, 33(13): doi 10.1088/1361-6528/ac44e8.
DOI Google Scholar
80.
TalSHadannyASassonEHyperbaric oxygen therapy can induce angiogenesis and regeneration of nerve fibers in traumatic brain injury patientsFront Hum Neurosci201711508

Tal S, Hadanny A, Sasson E, et al. Hyperbaric oxygen therapy can induce angiogenesis and regeneration of nerve fibers in traumatic brain injury patients. Front Hum Neurosci. 2017, 11: 508.

10.3389/fnhum.2017.00508
DOI Google Scholar
81.
LuYZhouXSChengJCEarly intensified rehabilitation training with hyperbaric oxygen therapy improves functional disorders and prognosis of patients with traumatic brain injuryAdv Wound Care2021101266367010.1089/wound.2018.0876

Lu Y, Zhou XS, Cheng JC, et al. Early intensified rehabilitation training with hyperbaric oxygen therapy improves functional disorders and prognosis of patients with traumatic brain injury. Adv Wound Care. 2021, 10(12): 663-670.
DOI Google Scholar
82.
ZhangQLiuJXCaoRAcupuncture for patients in Coma after traumatic brain injury: systematic review and meta-analysisAlternative Ther Health Med2020264505710.1117/12.2545291

Zhang Q, Liu JX, Cao R, et al. Acupuncture for patients in Coma after traumatic brain injury: systematic review and meta-analysis. Alternative Ther Health Med. 2020, 26(4): 50-57.
DOI Google Scholar
83.
XieRWangYFHeJHAcupuncture treatment for spasticity after brain injuryJ Neurorestoratol202191607110.26599/jnr.2021.9040001

Xie R, Wang YF, He JH, et al. Acupuncture treatment for spasticity after brain injury. J Neurorestoratol. 2021, 9(1): 60-71.
DOI Google Scholar
File
jnrt-10-2-100005_ESM.docx (20 KB)
Publication history
Copyright
Rights and permissions

Publication history

Received: 15 November 2021
Revised: 25 January 2022
Accepted: 13 February 2022
Published: 14 June 2022
Issue date: June 2022

Copyright

© 2022 The Authors. Published by Elsevier Ltd on behalf of Tsinghua University Press.

Rights and permissions

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return